Duda Monika K, O'Shea Karen M, Stanley William C
Zakład Fizjologii Klinicznej, Centrum Medyczne Kształcenia Podyplomowego, Warszawa.
Kardiol Pol. 2010;68 Suppl 5:S400-4.
Despite aggressive pharmacotherapy, heart failure is still clinical problem. Current therapies improve clinical symptoms and slow progression to heart failure, but overall the prognosis remains poor. Evidence from epidemiological, clinical and experimental studies indicates a beneficial role of the omega-3 polyunsaturated fatty acids (omega-3 PUFA) found in fish oils in the prevention and management of heart failure. Although the mechanisms is still unclear, clinical and animals studies indicate that the benefits of omega-3 PUFA may be attributed to a number of distinct biological effects on lipoprotein metabolism, inflammation response and mitochondrial function. This review summarise the data related to use of omega-3 PUFA supplementation as a potential treatment for heart failure and discussed possible mechanism of action.
尽管采用了积极的药物治疗,但心力衰竭仍然是一个临床问题。目前的治疗方法可改善临床症状并减缓心力衰竭的进展,但总体预后仍然很差。流行病学、临床和实验研究的证据表明,鱼油中发现的ω-3多不饱和脂肪酸(ω-3 PUFA)在心力衰竭的预防和管理中具有有益作用。虽然其机制尚不清楚,但临床和动物研究表明,ω-3 PUFA的益处可能归因于对脂蛋白代谢、炎症反应和线粒体功能的一些独特生物学效应。本综述总结了与使用ω-3 PUFA补充剂作为心力衰竭潜在治疗方法相关的数据,并讨论了可能的作用机制。